Biophysical investigation of recombinant K5 lyase: Structural implications of substrate binding and processing

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 1, 2007, Pages 72-77

  Rek, Angelika ^a   Thompson, James ^b   Roberts, Ian S ^b   Kungl, Andreas J ^a,c  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ProtAffin Biotechnologie AG   (Austria)

Author keywords

Carbohydrate; Circular dichroism; Fluorescence; Glycosaminoglycan; K5 lyase

Indexed keywords

CHONDROITIN SULFATE; HEPARAN SULFATE; HEPARIN; K5 LYASE; LIGAND; LYASE; POLYSACCHARIDE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ACETYLATION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CELL; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; COLIPHAGE; DEGRADATION; ENCAPSULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; FLUORESCENCE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SULFATION; TITRIMETRY; ULTRAVIOLET SPECTROSCOPY;

CHONDROITIN SULFATES; CIRCULAR DICHROISM; ENZYME STABILITY; ESCHERICHIA COLI PROTEINS; HEAT; HEPARITIN SULFATE; KINETICS; POLYSACCHARIDE-LYASES; PROTEIN DENATURATION; RECOMBINANT PROTEINS; ULTRAVIOLET RAYS;

EID: 33846081621     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.10.017     Document Type: Article

References (26)

1. Clarke B.R., Esumeh F., and Roberts I.S. Cloning, expression, and purification of the K5 capsular polysaccharide Lyase (KflA) from coliphage K5A: evidence for two distinct K5 Lyase enzymes. J. Bacteriol. 182 (2000) 3761-3766
2. Gupta D.S., Jann B., Schmidt G., Golecki J.R., Orskov I., Orskov F., and Jann K. Coliphage K5, specific for E. coli exhibiting the capsular K5 antigen. FEMS Microbiol. Lett. 14 (1982) 75-78
3. Roberts I.S. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50 (1996) 285-315
4. Whittaker D.V., Parolis L.A., and Parolis H. Escherichia coli K48 capsular polysaccharide: a glycan containing a novel diacetamido sugar. Carbohydr. Res. 256 (1994) 289-301
5. Shen G.J., Datta A.K., Izumi M., Koeller K.M., and Wong C.H. Expression of alpha2,8/2,9-polysialyltransferase from Escherichia coli K92. Characterisation of the enzyme and its reaction products. J. Biol. Chem. 274 (1999) 35139-35146
6. Whitfield C., and Roberts J.S. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol. Microbiol. 31 (1999) 1307-1319
7. Sutherland I.W. Polysaccharide lyases. FEMS Microbiol. Rev. 16 (1995) 323-347
8. Vann W.F., Schmidt M.A., Jann B., and Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli O10:K5:H4. A polymer similar to desulfo-heparin. Eur. J. Biochem. 116 (1981) 359-364
9. Sasisekharan R., and Venkataraman G. Heparin and heparan sulfate: biosynthesis, structure and function. Curr. Opin. Chem. Biol. 4 (2000) 626-631
10. Hänfling P., Shashkov A.S., Jann B., and Jann K. Analysis of the enzymatic cleavage (β elimination) of the capsular K5 polysaccharide of Escherichia coli by the K5-specific coliphage: a reexamination. J. Bacteriol. 178 (1996) 4747-4750
11. Murphy K.J., Merry C.L.R., Lyon M., Thompson J.E., Roberts I.S., and Gallagher J.T. A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. J. Biol. Chem. 279 (2004) 27239-27245
12. Naggi A., Torri G., Casu B., Oreste P., Zoppetti G., Li J.P., and Lindahl U. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide. Semin. Thromb. Hemost. 27 (2001) 437-443
13. Lindahl U., J.-P., Li, Kusche-Gullberg M., Salmivirta M., Alaranta S., Veromma T., Emeis J., Roberts I.S., Taylor C., Ureste P., Zoppetti G., Torri G., and Casu B. Generation of neoheparin from E. coli K5 capsular polysaccharide. J. Med. Chem. 48 (2005) 349-352
14. Razi N., Feyzi E., Bjork I., Naggi A., Casu B., and Lindahl U. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide. Biochem. J. 309 (1995) 465-472
15. Vicenzi E., Gatti A., Ghezzi S., Oreste P., Zoppetti G., and Poli G. Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives. AIDS 17 (2003) 177-181
16. Leali D., Belleri M., Urbinati C., Coltrini D., Oreste P., Zoppetti G., Ribatti D., Rusnati M., and Presta M. Fibroblast growth factor-2 antagonistic activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J. Biol. Chem. 276 (2001) 37900-37908
17. Lidholt K., Fjelstad M., Jann K., and Lindahl U. Substrate specificities of glycosyltransferases involved in formation of heparin precursor and E. coli K5 capsular polysaccharides. Carbohydr. Res. 2 (1994) 87-101
18. Kusche M., Hannesson H.H., and Lindahl U. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. Biochem. J. 275 (1991) 151-158
19. Legoux R., Lelong P., Jourde C., Feuillerat C., Capdevielle J., Sure V., Ferran E., Kaghad M., Delpech B., Shire D., Ferrara P., Loison G., and Salomé M. N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression. J. Bacteriol. 178 (1996) 7260-7264
20. Nomanbhoy T.K., and Cerione R. Characterisation of the interaction between RhoGDI and Cdc42Hs using fluorescence spectroscopy. J. Biol. Chem. 271 (1996) 10004-10009
21. Goger B., Halden Y., Rek A., Mösl R., Pye D., Gallagher J., and Kungl A.J. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 4 (2002) 1640-1646
22. Sreerama N., and Woody R.W. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal. Biochem. 209 (1993) 32-44
23. Rost B., and Liu J. The PredictProtein server. Nucleic Acids Res. 31 (2003) 3300-3304
24. Gunay N.S., and Linhardt R.J. Heparanoids: structure, biological activities, and therapeutic applications. Planta Med. 65 (1999) 301-306
25. Hileman R.E., Fromm J.R., Weiler J.M., and Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays 20 (1998) 156-167
26. Cardin A.D., and Weintraub H.J.R. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9 (1989) 21-32